Abstract
What does prenatal diagnosis mean?
Acknowledgments The author would like to thank Dr. Büşra Aynalı who contributed to this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Cunningham F, Leveno KJ, Bloom SL, et al. Prenatal diagnosis. In: Williams obstetrics. 25th ed. New York: McGraw-Hill; 2018. p. 277–300.
Messerlian GM, Palomaki GE. Down syndrome: overview of prenatal screening. UpToDate (09 Nov 2018). https://www.uptodate.com/contents/down-syndrome-overview-of-prenatal-screening.
ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459.
Palomaki GE, Messerlian GM, Halliday JV. Prenatal screening for common aneuploidies using cell-free DNA. UpToDate (21 Sept 2018). https://www.uptodate.com/contents/prenatal-screening-for-common-aneuploidies-using-cell-free-dna.
Committee on Practice Bulletins—Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine. Practice Bulletin No. 163: screening for fetal aneuploidy. Obstet Gynecol. 2016;127:e123.
Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126:e31. Reaffirmed 2017.
Ghidini A. Diagnostic amniocentesis. UpToDate (25 Sep 2017). https://www.uptodate.com/contents/diagnostic-amniocentesis.
Dukhovny S, Wilkins-Haug L. Open neural tube defects: risk factors, prenatal screening and diagnosis, and pregnancy management. UpToDate (18 Dec 2018). https://www.uptodate.com/contents/open-neural-tube-defects-risk-factors-prenatal-screening-and-diagnosis-and-pregnancy-management.
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 187: neural tube defects. Obstet Gynecol. 2017;130:e279.
Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian R. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester. Clin Chem. 2004;50:1804–8.
Kabagambe SK, Jensen GW, Chen YJ, Vanover MA, Farmer DL. Fetal surgery for myelomeningocele: a systematic review and meta-analysis of outcomes in fetoscopic versus open repair. Fetal Diagn Ther. 2018;43(3):161–74.
Farmer DL, Thom EA, Brock IIIJW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Gupta N, Adzick NS, Management of Myelomeningocele Study Investigators. The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol. 2018;218(2):256–e1.
Adzick NS, Thom EA, Spong CY, Brock JW III, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993–1004.
Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;9(9):CD003252. https://doi.org/10.1002/14651858.CD003252.pub2. PubMed PMID: 28869276; PubMed Central PMCID: PMC6483702.
Carlson LM, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin North Am. 2017;44(2):245–56. https://doi.org/10.1016/j.ogc.2017.02.004. PubMed PMID: 28499534; PubMed Central PMCID: PMC5548328.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sel, G. (2020). Prenatal Invasive Procedures. In: Practical Guide to Oral Exams in Obstetrics and Gynecology . Springer, Cham. https://doi.org/10.1007/978-3-030-29669-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-29669-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29668-1
Online ISBN: 978-3-030-29669-8
eBook Packages: MedicineMedicine (R0)